Muscle-invasive Urothelial Carcinoma Clinical Trials in Bari, Apulia

A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-risk Muscle-invasive Urothelial Carcinoma (MIUC)